Investor Calendar is powered by PrecisionIR, the leading webcaster of official investor relations events, and offers free access to live and archived corporate communications
 
  Home     Calendar     Conferences     Roadshows     Forums     Alerts     Research     Support     Podcast  
  Santarus, Inc. (SNTS) www.santarus.com
Santarus, Inc.

Enter your email address to receive alerts about this company
Help
March 26, 2009 - 12:00 PM Eastern
Lippert/Heilshorn Life Sciences Conference Presentation


      More company presentations from
                    		 
 
Information contained in this webcast is current as of the date and time first presented. The use of pop-up blocking or firewall software may prevent you from accessing this webcast. Please temporarily disable any of these products you may have while attempting to access this event.
About The Company
Santarus, Inc.
(Nasdaq:SNTS)

A specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists and other physicians. Current commercial efforts are focused on ZEGERID® (omeprazole/sodium bicarbonate), which is indicated for the treatment of certain upper GI diseases and disorders, and on GLUMETZA® (metformin hydrochloride extended release tablets), which is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. Also developing two lower GI product candidates, budesonide MMX® and rifamycin SV MMX®, for the U.S. market.

Recent news:
• Reported total revenues of $110.1 million and net income of $7.6 million for the nine months ended September 30, 2009.

• In December 2009 earned a $20 million milestone under a license agreement with Schering-Plough Healthcare Products, Inc. (consumer healthcare division of Merck & Co., Inc.) upon FDA approval of ZEGERID OTC™ for over-the-counter treatment of frequent heartburn.

• In December 2009 received FDA approval of new immediate-release dual buffer omeprazole tablet for the treatment of gastroesophageal reflux disease and certain other upper GI conditions

Market Assistant
Earnings Data
Annual Report
Related Events (times are Eastern) Show times in :
Company NameTicker Date/TimeTypeAlertsAudioPodcastVideoSlidesAnnual
Report
Santarus, Inc. SNTS  Dec 15, 2009 
@ 10:30am 		Lippert/Heilshorn Life Sciences ConferenceSignup for email alerts about this company's events and news         
Santarus, Inc. SNTS  Apr 28, 2009 
@ 10:00am 		Biopharma/Healthcare Investor Forum PresentationSignup for email alerts about this company's events and news         
Santarus, Inc. SNTS  Mar 26, 2009 
@ 12:00pm 		Lippert/Heilshorn Life Sciences Conference PresentationSignup for email alerts about this company's events and news            

Comments or questions? Click Here

Privacy Statement Terms and Conditions


©2000-2013 PrecisionIR. All rights reserved.
   
 

A part of PrecisionIR Group, www.PrecisionIR.com
601 Moorefield Park Drive, Richmond, VA 23236
145 Cannon Street, London, EC4N 5BQ, UK (Registered in England No 2394368)
Strandvägen 7A, 114 56 Stockholm, Sweden